News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Continue Reading Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Related Stories News Universal Digital Announces Amended and Restated Promissory Note with Conversion Rights News RIWI Releases Q1 2026 Financials and Announces Issuance of Stock Options News SATO Technologies Corp. Announces Annual General and Special Meeting, Including Proposed Stock Option Repricing, Term Extension, and Share Consolidation News Voghion Enhances Product Discovery to Surface More Niche and Long-Tail Products News CEO.CA’s Inside the Boardroom: Awalé Resources Hits Key Milestone with 1.71 Moz AuEq. MRE at Odienné News Theralase(R) Closes C$4.8 Million Offering
